FDA Elevates New Blood Pressure Medication Recall to Class II

Chlorthalidone Recall Covers 13,567 Bottles of Blood Pressure Medication

A chlorthalidone recall is affecting 13,567 bottles of the blood pressure medication distributed across the United States after tablets from one batch failed a test measuring how they dissolve. It is the second recall of Inventia Healthcare Limited’s chlorthalidone tablets for the same reason this year. The affected medicine is Chlorthalidone Tablets, USP, 25 mg, […]

FDA elevates new blood pressure medication recall to Class II

On September 17, the FDA classified an ongoing voluntary recall of chlorthalidone tablets, which are used to treat high blood pressure, as a Class II recall.

Chlorthalidone FDA Recall: Why the Blood Pressure Tablets Were Recalled

Inventia Healthcare’s chlorthalidone recall is drawing attention after the FDA assigned it a Class II classification. Learn about the dissolution testing issue and affected tablets.

Blood pressure medication recalled nationwide. See affected drug

More than 25,000 bottles of this blood pressure medication has been recalled. Here's the affected drug and reasoning behind the recall.

Blood pressure medication recalled nationwide under FDA's Class II risk level

If you are one of millions of Americans taking medication to lower blood pressure, you may want to check the label.

Blood pressure medication recalled nationwide after failing FDA dissolution testing

The recall covers 13,567 bottles of 25 mg chlorthalidone tablets made by Inventia Healthcare Limited.